Eiken Chemical Co., Ltd. (TYO:4549)
Japan
· Delayed Price · Currency is JPY 2,020.00
+8.00 (0.40%)
Jun 6, 2025, 3:30 PM JST
Eiken Chemical Revenue
In the fiscal year ending March 31, 2025, Eiken Chemical had annual revenue of 40.54B JPY with 1.22% growth. Eiken Chemical had revenue of 9.90B in the quarter ending March 31, 2025, with 3.56% growth.
Revenue
40.54B
Revenue Growth
+1.22%
P/S Ratio
1.65
Revenue / Employee
53.55M
Employees
757
Market Cap
66.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 40.54B | 487.00M | 1.22% |
| Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
| Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
| Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
| Mar 31, 2021 | 38.67B | 2.08B | 5.69% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |